The side effects of bacillus calmette-guerin in the treatment of TA Ti bladder cancer do not predict its efficacy: Results from an eortic genito-urinary group phase III trial

Author: Sylvester R.   Van der Meijden A.P.M.   Oosterlinck W.   Casetta G.   Hoeltl W.   Bono A.  

Publisher: Elsevier

ISSN: 1569-9056

Source: European Urology Supplements, Vol.2, Iss.1, 2003-02, pp. : 191-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content